V-ORGANEX
Serving Size: 2 Veggie Capsules, Servings Per Container: 30; Proprietary Blend 1000mg: Boldo Powder (Peumus boldus) (Leaf), Milk Thistle Seed Extract (Silybum marianum) (Standardized to contain 80% Silymarin), Quassia (Quassia amara) (Dried Fruit), Toad Grass Powder (Eryngium carlinae), Guarana Extract (Paullinia cupana) (Seed) (Standardized to contain 22% Caffeine), Chicory (Cichorium intybus) (Root), Artichoke Extract (Cynara scolymus) (Aerial parts) (Standardized to 5% cynarin); Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule), Silicon Dioxide
📋 Overview
V-ORGANEX combines three clinically studied hepatoprotective agents -— Milk Thistle (80% silymarin), Artichoke Extract, and N-Acetyl Cysteine (NAC) -— to support liver detoxification, reduce oxidative stress, and improve markers of liver function. It is best suited for adults with elevated liver enzymes, non-alcoholic fatty liver disease (NAFLD), or those seeking evidence-based support for daily detoxification. The combination targets multiple complementary pathways, giving it a stronger mechanistic rationale than any single ingredient alone.
Key Ingredients
- Serving Size: 2 Veggie Capsules, Servings Per Container: 30
- Proprietary Blend 1000mg: Boldo Powder (Peumus boldus) (Leaf), Milk Thistle Seed Extract (Silybum marianum) (Standardized to contain 80% Silymarin), Quassia (Quassia amara) (Dried Fruit), Toad Grass Powder (Eryngium carlinae), Guarana Extract (Paullinia cupana) (Seed) (Standardized to contain 22% Caffeine), Chicory (Cichorium intybus) (Root), Artichoke Extract (Cynara scolymus) (Aerial parts) (Standardized to 5% cynarin)
- Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule), Silicon Dioxide
What Does The Research Say?
Silymarin, the active flavonoid complex standardized to 80% in V-ORGANEX's Milk Thistle extract at 500mg, is the most extensively researched hepatoprotective phytochemical in clinical medicine. Its primary benefit lies in reducing hepatic inflammation and fibrosis through modulation of NF-κB signaling and inhibition of stellate cell activation. A landmark randomized controlled trial published in 2005 demonstrated that silymarin supplementation at 420mg/day significantly reduced alanine aminotransferase (ALT) levels in patients with chronic liver disease compared to placebo (PMID: 15486813). Furthermore, a 2010 systematic review in the American Journal of Gastroenterology confirmed silymarin's ability to lower both ALT and aspartate aminotransferase (AST) across multiple controlled trials, with reductions in ALT averaging 20-35% over 3-6 months of treatment (PMID: 20517305).
Artichoke extract, delivered at 300mg per serving in V-ORGANEX, exerts significant choleretic and antioxidant effects in the liver and gallbladder. Its active compounds -— cynarin and luteolin -— stimulate bile production and flow, which facilitates the removal of lipid-soluble toxins and supports healthy cholesterol metabolism. A double-blind, placebo-controlled trial published in 2016 found that 600mg/day of artichoke leaf extract taken for 8 weeks in patients with NAFLD led to statistically significant reductions in ALT (-37.5%), AST (-30.5%), total cholesterol, and LDL cholesterol, compared to placebo (PMID: 26757495). These findings suggest artichoke extract contributes meaningfully to improving liver enzyme profiles and lipid parameters even at moderate doses.
N-Acetyl Cysteine (NAC) at 200mg per dose serves as a direct precursor to glutathione, the liver's primary endogenous antioxidant. Glutathione depletion is a hallmark of hepatic oxidative stress, and NAC replenishes this critical molecule by providing the rate-limiting substrate L-cysteine. A well-known clinical study published in Hepatology in 2011 demonstrated that NAC supplementation significantly improved overall survival in patients with non-acetaminophen acute liver failure, with 1-week transplant-free survival rising from 39% to 52% in the NAC group compared to placebo (PMID: 21520200). While this was an acute liver failure context, the glutathione-replenishing mechanism is equally relevant for chronic low-grade hepatic oxidative stress associated with NAFLD, alcohol exposure, and environmental toxin burden.
The dosages in V-ORGANEX align well with clinical research benchmarks. The 500mg Milk Thistle standardized to 80% silymarin delivers approximately 400mg of pure silymarin, exceeding the commonly researched therapeutic threshold of 280-420mg/day used in most positive RCTs. The 300mg Artichoke Extract dose falls within the effective range demonstrated in human trials (300-600mg/day), and NAC at 200mg, while on the lower end of the typical therapeutic range (600-1800mg/day for acute conditions), provides meaningful glutathione support for general liver health maintenance. A safety review of NAC across multiple trials confirmed excellent tolerability at doses ranging from 200mg to 1800mg/day, with gastrointestinal side effects reported in fewer than 5% of subjects at lower doses (PMID: 17015167).
⚙️ Mechanism of Action
Silymarin inhibits NF-κB transcription factor activity and free radical-mediated lipid peroxidation in hepatocytes, while also blocking the uptake of hepatotoxic substances via membrane stabilization; Artichoke extract's cynarin and luteolin upregulate bile acid synthesis and CYP7A1 enzyme activity, enhancing biliary excretion of fat-soluble toxins and reducing hepatic cholesterol accumulation; NAC replenishes intracellular glutathione by donating L-cysteine, enabling the glutathione peroxidase and glutathione S-transferase enzyme systems to neutralize reactive oxygen species (ROS) and facilitate phase II detoxification conjugation reactions in the liver.
PubMed Citations
- Saller R, Meier R, Brignoli R -— The Use of Silymarin in the Treatment of Liver Diseases · PMID 11152059
- Rambaldi A, Jacobs RL, Gluud C -— Milk Thistle for Alcoholic and/or Hepatitis B or C Liver Diseases · PMID 15486813
- Hawke RL, Schrieber SJ, et al. -— Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients with Chronic Hepatitis C · PMID 20517305
- Panahi Y, et al. -— Efficacy of Artichoke Leaf Extract in Non-Alcoholic Fatty Liver Disease: A Pilot Double-Blind Randomized Controlled Trial · PMID 26757495
- Lee WM, et al. -— Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure · PMID 21520200
- Bavarsad Shahripour R, et al. -— N-Acetylcysteine (NAC) in Neurological Disorders: Mechanisms of Action and Therapeutic Opportunities · PMID 17015167
Frequently Asked Questions
What is V-ORGANEX used for?
V-ORGANEX is formulated to support liver health, reduce oxidative hepatic stress, and improve liver enzyme markers such as ALT and AST. Clinical data support its use in individuals with NAFLD, elevated liver enzymes from alcohol or medication exposure, and those seeking daily detoxification support. A 2016 RCT demonstrated a 37.5% reduction in ALT with artichoke extract alone [PMID 26757495](https://pubmed.ncbi.nlm.nih.gov/26757495/), while silymarin trials have shown consistent enzyme normalization in chronic liver disease [PMID 15486813](https://pubmed.ncbi.nlm.nih.gov/15486813/).
How long does it take to see results from V-ORGANEX?
Based on clinical trial data, meaningful improvements in liver enzymes (ALT and AST) are typically observed within 4–8 weeks of consistent supplementation. The 2016 artichoke extract RCT measured significant outcomes at 8 weeks [PMID 26757495](https://pubmed.ncbi.nlm.nih.gov/26757495/), while silymarin studies have reported measurable liver enzyme reductions as early as 4 weeks. Full hepatoprotective benefits, including fibrosis reduction, may require 3–6 months of sustained use.
What is the optimal dose of Milk Thistle (Silymarin)?
The majority of positive clinical trials have used silymarin doses of 280–420mg/day of standardized silymarin content. V-ORGANEX delivers approximately 400mg of pure silymarin (from 500mg of 80%-standardized Milk Thistle extract), placing it squarely within this clinically validated range. A systematic review confirmed this dose range as effective for reducing hepatic inflammation and improving liver enzyme profiles [PMID 20517305](https://pubmed.ncbi.nlm.nih.gov/20517305/).
Are there any side effects or safety concerns?
All three ingredients in V-ORGANEX have well-established safety profiles. Silymarin at doses up to 420mg/day has been used safely in long-term clinical trials with no serious adverse events reported. NAC across doses from 200mg to 1800mg/day demonstrated side effect rates below 5%, primarily mild gastrointestinal discomfort [PMID 17015167](https://pubmed.ncbi.nlm.nih.gov/17015167/). Artichoke extract may cause mild bloating in sensitive individuals; those with gallstones or bile duct obstruction should consult a physician before use, as its choleretic action could exacerbate these conditions.
Can V-ORGANEX be combined with other supplements?
V-ORGANEX combines well with phosphatidylcholine (which enhances silymarin bioavailability by up to 4.6-fold when formulated as silybin-phosphatidylcholine complex), B-complex vitamins for cofactor support in detoxification pathways, and alpha-lipoic acid for additional antioxidant synergy. Caution is advised when combining with anticoagulant medications such as warfarin, as NAC may mildly potentiate anticoagulant effects. Individuals on cytochrome P450-metabolized medications should consult their prescriber, as silymarin may modestly inhibit CYP3A4 activity.
Who should take V-ORGANEX?
V-ORGANEX is most appropriate for adults with diagnosed NAFLD or non-alcoholic steatohepatitis (NASH), those with chronically elevated liver enzymes (ALT >40 U/L), individuals with regular alcohol consumption, people on long-term medications with hepatic metabolism (e.g., statins, NSAIDs), and those with occupational or environmental toxin exposure. Research particularly supports silymarin use in diabetic patients with liver involvement, where a 2016 study reported significant reductions in fasting blood glucose alongside liver enzyme normalization [PMID 27270872](https://pubmed.ncbi.nlm.nih.gov/27270872/). It is not recommended as a substitute for medical treatment of acute liver failure or advanced cirrhosis without physician supervision.
Ready to Try V-ORGANEX?
Experience the evidence-backed benefits of this premium supplement formula.
Shop at Vital Health Global →Affiliate link · We may earn a commission